SKOLNICK PHIL (Chief Scientific Officer) sold 6.3% of their position (1.52K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $39.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/27/2022ACC: 0001385508-22-000026
Officer· Chief Scientific Officer
Since Oct 2018
-1.52K
Net shares
Net seller
$39.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.52K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.52K
Price / share
$26.19
Trade value
$39.76K
% of position
6.3%
1/27/2022
23.96K→22.45K
Total
Net shares
−1.52K
Net value
-$39.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2022 | S · Sale | −1.52K | $26.19 | $39.76K | 6.3% | 23.96K | 22.45K |
| Total | −1.52K | -$39.76K | ||||||
Derivative Transactions0
No derivative transactions reported